Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05539521
Other study ID # WUHICU202202
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date September 5, 2022
Est. completion date March 2023

Study information

Verified date September 2022
Source Wuhan Union Hospital, China
Contact Xiaobo Yang, MD
Phone +8602785351606
Email want.tofly@aliyun.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of remimazolam besylate compared to propofol for sedation in critically ill patients with deep sedation.


Description:

This is a single-center, prospective, randomized, controlled study using remimazolam besylate and propofol for sedation in critically ill patients with deep sedation. Subjects are randomized to remimazolam group and propofol group in a 1:1 ratio. Remifentanil is administered as the analgesic. Efficacy and safety profiles of remimazolam besylate are to be evaluated.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 2023
Est. primary completion date February 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Age = 18 and = 80 years; - Expected to require deep sedation =8 hours; - Requirement for deep sedation (a Narcotrend index between 13 and 64). Exclusion Criteria: - Body mass index (BMI) <18 or >30 kg/m2; - Acute severe neurological disorder and any other condition interfering with RASS assessment; - Systolic blood pressure less than 90 mm Hg after appropriate intravenous volume replacement and continuous infusions of 2 vasopressors; - Heart rate less than 50 beats/min; - Second- or third-degree heart block in the absence of a pacemaker; - Unstable angina; - Acute myocardial infarction; - Left ventricular ejection fraction less than 30%; - Contraindicate or allergic to study drugs; - Moribund state; - Acute hepatitis or serious hepatic dysfunction (Child-Pugh class C); - Chronic kidney disease with glomerular filtration rate (GFR) < 60 ml/min/1.73m2; - Alcohol abuse; - Myasthenia gravis; - Expected to have a general anesthesia within 8 hours; - Pregnancy or lactation.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Remimazolam Besylate
sedation drugs
Propofol
Propofol

Locations

Country Name City State
China Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan

Sponsors (1)

Lead Sponsor Collaborator
Wuhan Union Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The percentage of time in the target sedation range without rescue sedation The percentage of time in the target sedation range without rescue sedation From the beginning of using study sedatives until being discharged from our ICU, the sedation target was changed, 48 hours after enrollment, or dead, whichever came first
Secondary Adverse events Adverse events From the beginning of using study sedatives until being discharged from our ICU, the sedation target was changed, 48 hours after enrollment, or dead, whichever came first
Secondary 7-day ventitlator free time 7-day ventitlator free time From start of study to 7 days
Secondary Extubation at day 7 Extubation at day 7 From start of study to 7 days
Secondary Length of ICU stay Length of ICU stay From start of study to 28 days
Secondary 28-day mortality 28-day mortality From start of study to 28 days
See also
  Status Clinical Trial Phase
Recruiting NCT04776486 - Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance N/A
Recruiting NCT05766319 - The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission N/A
Recruiting NCT03231540 - The PREServation of MUScle Function in Critically Ill Patients (PRESMUS) N/A
Completed NCT02286869 - Cardioventilatory Coupling in Critically Ill Patients N/A
Completed NCT01434823 - 24 Hour Intensivist Coverage in the Medical Intensive Care Unit N/A
Active, not recruiting NCT01142570 - Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients N/A
Completed NCT01167595 - Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients N/A
Completed NCT01293708 - Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:
Not yet recruiting NCT00916591 - Prokinetic Drugs and Enteral Nutrition N/A
Recruiting NCT00654797 - Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2 Phase 2
Withdrawn NCT00178321 - Improving Sleep in the Pediatric Intensive Care Unit N/A
Completed NCT01168128 - PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study N/A
Completed NCT02447692 - Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study N/A
Recruiting NCT04582760 - Early Mobilization in Ventilated sEpsis & Acute Respiratory Failure Study N/A
Not yet recruiting NCT05961631 - Bio-electrical Impedance Analysis Derived Parameters for Evaluating Fluid Accumulation
Completed NCT03276650 - Admission of Adult-onset Still Disease Patients in the ICU
Completed NCT03922113 - Muscle Function After Intensive Care
Recruiting NCT05055830 - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting NCT06027008 - Mechanical Insufflation-Exsufflation (Cough Assist) in Critically Ill Adults N/A
Recruiting NCT05531253 - Respired Gases in Patients Post Cardiac Surgery